Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/334449

Lähdeviite

Paavola , S , Lindfors , K , Kivelä , L , Cerqueira , J , Huhtala , H , Saavalainen , P , Tauschi , R , Kaukinen , K & Kurppa , K 2021 , ' Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives ' , Alimentary Pharmacology & Therapeutics , vol. 54 , no. 6 , pp. 805-813 . https://doi.org/10.1111/apt.16534

Julkaisun nimi: Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives
Tekijä: Paavola, Saana; Lindfors, Katri; Kivelä, Laura; Cerqueira, Juliana; Huhtala, Heini; Saavalainen, Päivi; Tauschi, Riku; Kaukinen, Katri; Kurppa, Kalle
Tekijän organisaatio: TRIMM - Translational Immunology Research Program
Immunomics
Department of Medical and Clinical Genetics
Päiväys: 2021-09
Kieli: eng
Sivumäärä: 9
Kuuluu julkaisusarjaan: Alimentary Pharmacology & Therapeutics
ISSN: 0269-2813
DOI-tunniste: https://doi.org/10.1111/apt.16534
URI: http://hdl.handle.net/10138/334449
Tiivistelmä: Background Family screening has been advocated as a means to reduce the major underdiagnosis of coeliac disease. However, the precise risk of the disease in relatives and the impact of patient- and relative-related individual factors remain obscure. Aims To investigate the individual risk of coeliac disease among patients' relatives. Methods Altogether 2943 relatives of 624 index patients were assessed for the presence of previous coeliac disease diagnosis, or were screened for the disease. Coeliac disease-associated human leucocyte antigen (HLA) genotype was determined from all participants. The association between individual factors and new screening positivity was assessed by logistic regression. Results There were 229 previously diagnosed non-index relatives with coeliac disease and 2714 non-affected (2067 first-degree, 647 more distant) relatives. Of these 2714 relatives, 129 (4.8%) were screening-positive (first-degree 5.1%, second-degree 3.6%, more distant 3.5%). The combined prevalence of the previously diagnosed and now detected cases in relatives was 12.2% (6.3% clinically detected, 5.9% screen-detected). In univariate analysis, age
Avainsanat: PEDIATRIC GASTROENTEROLOGY
UNITED-STATES
PREVALENCE
POPULATION
DIAGNOSIS
SYMPTOMS
SEROLOGY
CHILDREN
GUIDELINES
ANTIBODIES
3121 General medicine, internal medicine and other clinical medicine
317 Pharmacy
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by_nc_nd
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
apt.16534.pdf 472.9KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot